Sanofi (SNY)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- 7,813,000,000 40.5%
- Gross profit
- 33,667,000,000
- Operating income
- 6,344,000,000
- Earnings per share
- 6.40 44.1%
- R&D expense
- 7,842,000,000
Growth and profitability
- Return on equity
- 10.95
- Return on assets
- 6.16
Balance sheet
- Total assets
- 126,805,000,000
- Shareholders' equity
- 71,376,000,000
- Cash and equivalents
- 7,657,000,000
- Debt
- 18,702,000,000
- Net debt
- 11,045,000,000
- Current ratio
- 1.09
- Debt to equity
- 0.26
Cash flow and ratios
- Operating cash flow
- 10,750,000,000
- Interest coverage
- 11.27
Shareholder returns
- Share buybacks
- 5,030,000,000
- Shares outstanding
- 1,219,427,096
- Book value per share
- 58.53
Company information
- Headquarters
- Paris, I0
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Sanofi trades on NASDAQ under the ticker symbol SNY. This page brings together its price chart, company profile, key financial figures and technical indicators.